Faisal is a healthcare executive leader with proven results at some of the most successful healthcare technology companies; Change Healthcare (NASDAQ: CHNG), Allscripts Healthcare (NASDAQ: MDRX) and Neoforma (NASDAQ: NEOF).

Faisal has built new and has turned-around SaaS based businesses. He has led multiple P&Ls, simultaneously. He has launched healthcare data solutions, clinical interoperability solutions, Electronic Medical Record (EMR) solutions, Revenue Cycle Management (RCM) solutions, Patient Access solutions and clinical trials recruitment solutions. Faisal has built and scaled global organizations of 2200+ team members.

Most recently, Faisal founded a division at Change Healthcare and grew it to $45M+ rev, 50+% margin. The Clinical Networks Division operated the largest national clinical interoperability network, enabling clinical data exchange among providers, and with health plans. The network is in use by health plans and Change Healthcare’s Payer Analytics business units. Faisal led strategic venture investment in BEK Health, a provider of AI based clinical trials recruitment.

Faisal also founded Veradigm, the fastest growing business at Allscripts Healthcare Solutions with revenue exceeding $160M+ and 60+% margin. He was one of the executive leaders responsible for growing Allscripts from 600 employees to over 7,000 employees and from $350 million in revenue to over $1.6 billion in annual revenue. He led the majority acquisition of Pulse8, a provider of Payer Analytics for ACA plans.

Faisal led product/r&d integration for Misys/Allscripts’s $800M merger and Allscripts/Eclipsys’s $1.5B merger. He rationalized complex portfolios and achieved M&A synergy goals.

As the CEO of Truveris, a cloud-based solution for drug price transparency, Faisal led growth in revenue from $9.4M to $34.2M over a two-year period. He achieved positive cash flow and raised $25M in growth funding led by McKesson Ventures after a highly competitive process.

Faisal has been a frequent speaker at industry conferences such as CNBC Healthy Returns summit. He has co-authored four patents in sentiment analysis (Natural Language Processing) and Machine Learning (ML) techniques for processing large data sets.